GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Lotte Tour Development Co Ltd (XKRX:032350) » Definitions » Other Net Income (Loss)

Lotte Tour Development Co (XKRX:032350) Other Net Income (Loss) : ₩0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Lotte Tour Development Co Other Net Income (Loss)?

Lotte Tour Development Co's Other Net Income (Loss) for the three months ended in Mar. 2025 was ₩-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩0 Mil.

Lotte Tour Development Co's quarterly Other Net Income (Loss) declined from Sep. 2024 (₩0 Mil) to Dec. 2024 (₩0 Mil) and declined from Dec. 2024 (₩0 Mil) to Mar. 2025 (₩-0 Mil).

Lotte Tour Development Co's annual Other Net Income (Loss) increased from Dec. 2022 (₩-0 Mil) to Dec. 2023 (₩0 Mil) but then declined from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩0 Mil).


Lotte Tour Development Co Other Net Income (Loss) Historical Data

The historical data trend for Lotte Tour Development Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotte Tour Development Co Other Net Income (Loss) Chart

Lotte Tour Development Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lotte Tour Development Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lotte Tour Development Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lotte Tour Development Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Lotte Tour Development Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Lotte Tour Development Co Business Description

Traded in Other Exchanges
N/A
Address
Gwanghwamun Building, 211 Sejongno, Jongno-gu, Seoul, KOR, 110730
Lotte Tour Development Co Ltd offers tourism services and chartered transportation business in South Korea. The company provides various types of travel products; special products, such as corporate (commercial) travel and cruise travel services; free and personalized travel, including general package products, as well as domestic and foreign travel agency services.

Lotte Tour Development Co Headlines

No Headlines